EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Correction to “Plasma p‐tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS‐HD”

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-04 · 18 (2)

DOI: 10.1002/dad2.70327 ↗

At a glance

Journal article in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, published online on 2026-03-31. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Abstract non disponibile.

Cite

APA

(2026). Correction to “Plasma p‐tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS‐HD”. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(2). https://doi.org/10.1002/dad2.70327

Vancouver

Correction to “Plasma p‐tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS‐HD”. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(2). doi:10.1002/dad2.70327

BibTeX
@article{euvimed2026,
  title = {Correction to “Plasma p‐tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS‐HD”},
  journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
  year = {2026},
  volume = {18},
  number = {2},
  doi = {10.1002/dad2.70327}
}
Start for free →